Jay Hoofnagle is director of the Liver Disease Research Branch at the National Institute of Diabetes and Digestive and Kidney Diseases. Stephen Morrissey, the interviewer, is the Executive Managing Editor of the Journal.

The bibliographic file:

Dr. Jay Hoofnagle. (2020). Interview with Dr. Jay Hoofnagle on the discovery of hepatitis C and progress in preventing and treating chronic infection.. 2020, de Managing Editor of the Journal Sitio web: https://www.nejm.org/action/showMediaPlayer?doi=10.1056%2FNEJMdo005913&aid=10.1056%2FNEJMp2031110&viewType=Popup&viewClass=Audio&ctype=audiointerview&area=production

Alzheimer e inflamación de encías: ¿qué relación tienen?

El Alzheimer es una de las enfermedades que más…

¿Nueva pandemia? La influenza H3N2 enciende las alarmas en Europa

La gripe H3N2, una variante de la influenza A,…

Hospital acquired drug resistant infections, deaths rose 15% from 2019-20: CDC

Hospital-acquired drug-resistant infections,…

Don’t let the term ‘elective’ fool you, physicians urge the public

According to Becker’s Hospital Review, the…

La controversial cirugía de estatura 

¿Alargamiento óseo? Así como lo lees, una de las…

ChatGPT Health: la nueva apuesta de OpenAI para consultas de salud

¿Una consulta médica con ChatGPT? La empresa…

Antibiotics significantly overprescribed during early months of pandemic, study suggests

According to a study recently shared by Becker’s…

Peptide makes drug-resistant bacteria sensitive to antibiotics again

The research team, led by Professors Kimberly…

EVIDENCIA CLÍNICA SYNOLIS VA®

CLÍNICA SYNOLIS VA® RENDIMIENTO  EN EL DOLOR Y…